Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
US9029338B2 · kind B2 · utility
0Cited by
5References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2010 |
| Grant date | May 12, 2015 |
| Priority date | — |
| Expiry date | Oct 26, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to lipid formulated double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.